Literature DB >> 24630180

Ecological validity and clinical utility of Patient-Reported Outcomes Measurement Information System (PROMIS®) instruments for detecting premenstrual symptoms of depression, anger, and fatigue.

Doerte U Junghaenel1, Stefan Schneider2, Arthur A Stone2, Christopher Christodoulou2, Joan E Broderick2.   

Abstract

OBJECTIVE: This study examined the ecological validity and clinical utility of NIH Patient Reported-Outcomes Measurement Information System (PROMIS®) instruments for anger, depression, and fatigue in women with premenstrual symptoms.
METHODS: One-hundred women completed daily diaries and weekly PROMIS assessments over 4weeks. Weekly assessments were administered through Computerized Adaptive Testing (CAT). Weekly CATs and corresponding daily scores were compared to evaluate ecological validity. To test clinical utility, we examined if CATs could detect changes in symptom levels, if these changes mirrored those obtained from daily scores, and if CATs could identify clinically meaningful premenstrual symptom change.
RESULTS: PROMIS CAT scores were higher in the pre-menstrual than the baseline (ps<.0001) and post-menstrual (ps<.0001) weeks. The correlations between CATs and aggregated daily scores ranged from .73 to .88 supporting ecological validity. Mean CAT scores showed systematic changes in accordance with the menstrual cycle and the magnitudes of the changes were similar to those obtained from the daily scores. Finally, Receiver Operating Characteristic (ROC) analyses demonstrated the ability of the CATs to discriminate between women with and without clinically meaningful premenstrual symptom change.
CONCLUSIONS: PROMIS CAT instruments for anger, depression, and fatigue demonstrated validity and utility in premenstrual symptom assessment. The results provide encouraging initial evidence of the utility of PROMIS instruments for the measurement of affective premenstrual symptoms.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anger; Depression; Fatigue; PROMIS®; Premenstrual symptoms; Validity

Mesh:

Year:  2014        PMID: 24630180      PMCID: PMC4162640          DOI: 10.1016/j.jpsychores.2014.01.010

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  36 in total

Review 1.  Is premenstrual dysphoric disorder a distinct clinical entity?

Authors:  J Endicott; J Amsterdam; E Eriksson; E Frank; E Freeman; R Hirschfeld; F Ling; B Parry; T Pearlstein; J Rosenbaum; D Rubinow; P Schmidt; S Severino; M Steiner; D E Stewart; S Thys-Jacobs
Journal:  J Womens Health Gend Based Med       Date:  1999-06

Review 2.  Premenstrual syndrome and premenstrual dysphoric disorder: definitions and diagnosis.

Authors:  Ellen W Freeman
Journal:  Psychoneuroendocrinology       Date:  2003-08       Impact factor: 4.905

3.  The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: attributable risk and risk factors.

Authors:  S Ramcharan; E J Love; G H Fick; A Goldfien
Journal:  J Clin Epidemiol       Date:  1992-04       Impact factor: 6.437

4.  Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Bryce B Reeve; Ron D Hays; Jakob B Bjorner; Karon F Cook; Paul K Crane; Jeanne A Teresi; David Thissen; Dennis A Revicki; David J Weiss; Ronald K Hambleton; Honghu Liu; Richard Gershon; Steven P Reise; Jin-shei Lai; David Cella
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

5.  Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.

Authors:  Teri Pearlstein; Kimberly A Yonkers; Rana Fayyad; John A Gillespie
Journal:  J Affect Disord       Date:  2005-04       Impact factor: 4.839

6.  Women's beliefs about the prevalence of premenstrual syndrome and biases in recall of premenstrual changes.

Authors:  M L Marván; S Cortés-Iniestra
Journal:  Health Psychol       Date:  2001-07       Impact factor: 4.267

Review 7.  Premenstrual syndrome.

Authors:  Lori M Dickerson; Pamela J Mazyck; Melissa H Hunter
Journal:  Am Fam Physician       Date:  2003-04-15       Impact factor: 3.292

8.  The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study.

Authors:  K R Merikangas; M Foeldenyi; J Angst
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

9.  Severity of premenstrual symptoms in a health maintenance organization population.

Authors:  Barbara Sternfeld; Ralph Swindle; Anita Chawla; Stacey Long; Sean Kennedy
Journal:  Obstet Gynecol       Date:  2002-06       Impact factor: 7.661

10.  Understanding recall of weekly pain from a momentary assessment perspective: absolute agreement, between- and within-person consistency, and judged change in weekly pain.

Authors:  Arthur A Stone; Joan E Broderick; Saul S Shiffman; Joseph E Schwartz
Journal:  Pain       Date:  2004-01       Impact factor: 6.961

View more
  7 in total

Review 1.  Ambulatory and diary methods can facilitate the measurement of patient-reported outcomes.

Authors:  Stefan Schneider; Arthur A Stone
Journal:  Qual Life Res       Date:  2015-06-23       Impact factor: 4.147

2.  Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN).

Authors:  Donna M Evon; Abdus S Wahed; Geoffrey Johnson; Mandana Khalili; Mauricio Lisker-Melman; Robert J Fontana; Souvik Sarkar; Bryce B Reeve; Jay H Hoofnagle
Journal:  Dig Dis Sci       Date:  2016-01-30       Impact factor: 3.199

3.  A randomized placebo-controlled trial of the effect of coffee consumption on insulin sensitivity: Design and baseline characteristics of the Coffee for METabolic Health (COMETH) study.

Authors:  Derrick Johnston Alperet; Salome Antonette Rebello; Eric Yin-Hao Khoo; Zoey Tay; Sharna Si-Ying Seah; Bee-Choo Tai; Shahram Emady-Azar; Chieh Jason Chou; Christian Darimont; Rob M van Dam
Journal:  Contemp Clin Trials Commun       Date:  2016-08-02

4.  Pragmatic cluster randomized trial to evaluate effectiveness and implementation of enhanced EHR-facilitated cancer symptom control (E2C2).

Authors:  Lila J Finney Rutten; Kathryn J Ruddy; Linda L Chlan; Joan M Griffin; Jeph Herrin; Aaron L Leppin; Deirdre R Pachman; Jennifer L Ridgeway; Parvez A Rahman; Curtis B Storlie; Patrick M Wilson; Andrea L Cheville
Journal:  Trials       Date:  2020-06-05       Impact factor: 2.279

5.  Early- and Late-Luteal-Phase Estrogen and Progesterone Levels of Women with Premenstrual Dysphoric Disorder.

Authors:  Ju-Yu Yen; Huang-Chi Lin; Pai-Cheng Lin; Tai-Ling Liu; Cheng-Yu Long; Chih-Hung Ko
Journal:  Int J Environ Res Public Health       Date:  2019-11-07       Impact factor: 3.390

6.  A Study of the Reliability and Validity of the Korean Version of DSM-5 Symptom Measure-Inattention and Anger for Parent and Guardian of Child Age 6 to 17.

Authors:  Min-Sup Shin; Bung-Nyun Kim; Minji Cho; Mirae Jang; Hanbyul Shin; Ryemi Do; Hyungseo Park; Narae Yoon; Gahye Noh; Jae-Won Song; Yebin Ahn; Jiyoon Shin; Soomin Jang; Eunjung Noh; Eunhwa Lee
Journal:  Soa Chongsonyon Chongsin Uihak       Date:  2021-04-01

7.  Cognitive problems following hematopoietic stem cell transplant: relationships with sleep, depression and fatigue.

Authors:  S E Ghazikhanian; C S Dorfman; T J Somers; M L O'Sullivan; H M Fisher; S N Edmond; A A Wren; S A Kelleher; K A Rowe Nichols; N Chao; R A Shelby
Journal:  Bone Marrow Transplant       Date:  2016-12-12       Impact factor: 5.483

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.